Tumor-initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long-term culturing as adherent monolayers

International Journal of Cancer

Volumn 132, Issue 3, 2013, Pages

  Kuch, Vanessa ^a   Schreiber, Caroline ^a   Thiele, Wilko ^a,b   Umansky, Viktor ^c   Sleeman, Jonathan P ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

cancer stem cell; cell culture; label retention; spheroid; tumor initiation

Indexed keywords

METHYLCELLULOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER STEM CELL; CELL AGGREGATION; CELL ISOLATION; CELL SUBPOPULATION; CELL SUSPENSION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA CELL; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SPHEROID CELL;

ANIMALS; BREAST NEOPLASMS; CELL AGGREGATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84870252931     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27785     Document Type: Article

References (50)

1. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44.
2. Visvader JE, Lindeman GJ,. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8: 755-68.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-8.
4. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67.
5. Liu JC, Deng T, Lehal RS, et al. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 2007; 67: 8671-81.
6. Cho RW, Wang X, Diehn M, et al. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 2008; 26: 364-71.
7. Grange C, Lanzardo S, Cavallo F, et al. Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 2008; 10: 1433-43.
8. Wright MH, Calcagno AM, Salcido CD, et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008; 10: R10.
9. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature 2008; 451: 345-9.
10. Monzani E, Facchetti F, Galmozzi E, et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43: 935-46.
11. Fang D, Nguyen TK, Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328-37.
12. Boonyaratanakornkit JB, Yue L, Strachan LR, et al. Selection of tumorigenic melanoma cells using ALDH. J Invest Dermatol 2010; 130: 2799-808.
13. Boiko AD, Razorenova OV, van de Rijn M, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-7.
14. Held MA, Curley DP, Dankort D, et al. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 2010; 70: 388-97.
15. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17: 1253-70.
16. Reynolds BA, Weiss S,. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996; 175: 1-13.
17. Todaro M, Alea MP, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389-402.
18. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005; 65: 5506-11.
19. Grimshaw MJ, Cooper L, Papazisis K, et al. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 2008; 10: R52.
20. Perego M, Tortoreto M, Tragni G, et al. Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells. J Invest Dermatol 2010; 130: 1877-86.
21. Botchkina GI, Zuniga ES, Das M, et al. New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Mol Cancer 2010; 9: 192.
22. Chen C, Wei Y, Hummel M, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011; 6: e16466.
23. Moore N, Lyle S,. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol 2011; 2011: 396076.
24. Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140: 62-73.
25. Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141: 583-94.
26. Fillmore CM, Kuperwasser C,. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008; 10: R25.
27. Dembinski JL, Krauss S,. Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma. Clin Exp Metastasis 2009; 26: 611-23.
28. Maenhaut C, Dumont JE, Roger PP, van Staveren WC,. Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 2010; 31: 149-58.
29. Prestegarden L, Enger PO,. Cancer stem cells in the central nervous system-a critical review. Cancer Res 2010; 70: 8255-8.
30. Wang ZA, Shen MM,. Revisiting the concept of cancer stem cells in prostate cancer. Oncogene 2011; 30: 1261-71.
31. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-8.
32. Greshock J, Nathanson K, Martin AM, et al. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res 2007; 67: 3594-600.
33. Lakshmikanth T, Burke S, Ali TH, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009; 119: 1251-63.
34. Hu Y, Smyth GK,. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347: 70-8.
35. Fantozzi A, Christofori G,. Mouse models of breast cancer metastasis. Breast Cancer Res 2006; 8: 212.
36. Sabisz M, Skladanowski A,. Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models. Cell Cycle 2009; 8: 3208-17.
37. Mosieniak G, Sikora E,. Polyploidy: the link between senescence and cancer. Curr Pharm Des 2010; 16: 734-40.
38. Kusumbe AP, Bapat SA,. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009; 69: 9245-53.
39. Jensen JB, Parmar M,. Strengths and limitations of the neurosphere culture system. Mol Neurobiol 2006; 34: 153-61.
40. Schatton T, Frank MH,. The in vitro spheroid melanoma cell culture assay: cues on tumor initiation? J Invest Dermatol 2010; 130: 1769-71.
41. Prasmickaite L, Engesaeter BO, Skrbo N, et al. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One 2010; 5: e10731.
42. Na YR, Seok SH, Kim DJ, et al. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumour Biol 2009; 30: 300-9.
43. Kai K, Nagano O, Sugihara E, et al. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci 2009; 100: 2275-82.
44. Ramgolam K, Lauriol J, Lalou C, et al. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One 2011; 6: e18784.
45. Matilainen H, Yu XW, Tang CW, et al. Sphere formation reverses the metastatic and cancer stem cell phenotype of the murine mammary tumour 4T1, independently of the putative cancer stem cell marker Sca-1. Cancer Lett 2012; 323: 20-8.
46. Kim RJ, Kim SR, Roh KJ, et al. Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer. Cancer Lett 2009; 287: 172-81.
47. Kleinman HK, Martin GR,. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005; 15: 378-86.
48. Hahne M, Wenger RH, Vestweber D, Nielsen PJ,. The heat-stable antigen can alter very late antigen 4-mediated adhesion. J Exp Med 1994; 179: 1391-5.
49. De Witt Hamer PC, Van Tilborg AA, Eijk PP, et al. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 2008; 27: 2091-6.
50. Daniel VC, Marchionni L, Hierman JS, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009; 69: 3364-73.